StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Maxim Group Downgrades Gilead Sciences (GILD) to Hold
October 25, 2019 7:42 AM
Maxim Group analyst Jason McCarthy downgraded Gilead Sciences (NASDAQ: GILD) from Buy to Hold.The analyst comments "We are positive on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Downgrades
Next Articles
Gilead Sciences (GILD), Glympse Bio Report Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development
October 28, 2019 8:05 AM